NTUSNATUS MEDICAL INC

Nasdaq www.natus.com


$ 32.95 $ 0.03 (0.09 %)    

Wednesday, 20-Jul-2022 15:59:55 EDT
QQQ $ 454.82 $ 3.15 (0.7 %)
DIA $ 398.57 $ -1.85 (-0.46 %)
SPY $ 530.36 $ 0.61 (0.12 %)
TLT $ 91.26 $ -0.27 (-0.3 %)
GLD $ 225.37 $ 0.90 (0.4 %)
$ 32.96
$ 26.41 x 133
$ 32.98 x 200
-- - --
$ 20.90 - $ 33.93
132,698
na
1.13B
$ 1.02
$ 89.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2022 03-31-2022 10-Q
2 02-25-2022 12-31-2021 10-K
3 11-05-2021 09-30-2021 10-Q
4 08-06-2021 06-30-2021 10-Q
5 05-07-2021 03-31-2021 10-Q
6 02-26-2021 12-31-2020 10-K
7 11-04-2020 09-30-2020 10-Q
8 08-04-2020 06-30-2020 10-Q
9 05-06-2020 03-31-2020 10-Q
10 03-02-2020 12-31-2019 10-K
11 11-06-2019 09-30-2019 10-Q
12 08-07-2019 06-30-2019 10-Q
13 05-08-2019 03-31-2019 10-Q
14 03-01-2019 12-31-2018 10-K
15 11-08-2018 09-30-2018 10-Q
16 08-08-2018 06-30-2018 10-Q
17 05-09-2018 03-31-2018 10-Q
18 03-01-2018 12-31-2017 10-K
19 11-06-2017 09-30-2017 10-Q
20 08-07-2017 06-30-2017 10-Q
21 05-08-2017 03-31-2017 10-Q
22 02-24-2017 12-31-2016 10-K
23 11-03-2016 09-30-2016 10-Q
24 08-03-2016 06-30-2016 10-Q
25 05-04-2016 03-31-2016 10-Q
26 02-29-2016 12-31-2015 10-K
27 11-04-2015 09-30-2015 10-Q
28 08-05-2015 06-30-2015 10-Q
29 05-06-2015 03-31-2015 10-Q
30 03-16-2015 12-31-2014 10-K
31 11-05-2014 09-30-2014 10-Q
32 08-08-2014 06-30-2014 10-Q
33 05-07-2014 03-31-2014 10-Q
34 03-17-2014 12-31-2013 10-K
35 11-07-2013 09-30-2013 10-Q
36 08-08-2013 06-30-2013 10-Q
37 05-21-2013 03-31-2013 10-Q
38 04-10-2013 12-31-2012 10-K
39 11-09-2012 09-30-2012 10-Q
40 08-08-2012 06-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20220721-1454377/1454377_6ntus.pdf

 natus-medical-q1-eps-022-misses-026-estimate-sales-11980m-beat-11570m-estimate

Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.26...

 earnings-scheduled-for-may-5-2022

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per...

 68-biggest-movers-from-yesterday
68 Biggest Movers From Yesterday
04/19/2022 08:35:35

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a mul...

 mid-afternoon-market-update-crude-oil-rises-over-1-nektar-therapeutics-shares-slide

U.S. stocks traded higher in volatile session, with the Dow Jones gaining around 60 points toward the end of trading on Monday.

 mid-day-market-update-us-stocks-turn-lower-bank-of-america-earnings-top-views

U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday.

 34-stocks-moving-in-mondays-mid-day-session

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract w...

 mid-morning-market-update-markets-open-higher-dow-gains-100-points

U.S. stocks traded higher this morning, with the Dow Jones adding around 100 points on Monday.

 benzingas-daily-brief-on-trending-tickers-for-april-18-2022-casa-systems-twitter-didi-global-and-more

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platfo...

 why-are-natus-medical-shares-trading-higher-today

Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare indus...

 natus-medical-q4-earnings-insights

Natus Medical (NASDAQ:NTUS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what inves...

 natus-medical-q4-eps-047-beats-044-estimate-sales-12870m-beat-12350m-estimate

Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.44 b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION